The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook

Pulmonary embolism (PE) is a common pathologic condition that frequently occurs in patients with deep venous thrombosis. Severe PE may critically suppress cardiopulmonary function, thereby threatening the life of patients. Chronic pulmonary hypertension caused by PE may lead to deterioration of resp...

Full description

Bibliographic Details
Main Authors: Mingyao Luo, Mingyuan Du, Chang Shu, Sheng Liu, Jiehua Li, Lei Zhang, Xin Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.743945/full
_version_ 1798014022952419328
author Mingyao Luo
Mingyuan Du
Mingyuan Du
Chang Shu
Chang Shu
Chang Shu
Sheng Liu
Jiehua Li
Jiehua Li
Lei Zhang
Lei Zhang
Xin Li
Xin Li
author_facet Mingyao Luo
Mingyuan Du
Mingyuan Du
Chang Shu
Chang Shu
Chang Shu
Sheng Liu
Jiehua Li
Jiehua Li
Lei Zhang
Lei Zhang
Xin Li
Xin Li
author_sort Mingyao Luo
collection DOAJ
description Pulmonary embolism (PE) is a common pathologic condition that frequently occurs in patients with deep venous thrombosis. Severe PE may critically suppress cardiopulmonary function, thereby threatening the life of patients. Chronic pulmonary hypertension caused by PE may lead to deterioration of respiratory dysfunction, resulting in complete disability. MicroRNAs (miRNAs) are a group of abundantly expressed non-coding RNAs that exert multiple functions in regulating the transcriptome via post-transcriptional targeting of mRNAs. Specifically, miRNAs bind to target mRNAs in a matching mechanism between the miRNA seed sequence and mRNA 3ʹ UTR, thus modulating the transcript stability or subsequent translation activity by RNA-induced silencing complex. Current studies have reported the function of miRNAs as biomarkers of PE, revealing their mechanism, function, and targetome in venous thrombophilia. This review summarizes the literature on miRNA functions and downstream mechanisms in PE. We conclude that various related miRNAs play important roles in PE and have great potential as treatment targets. For clinical application, we propose that miRNA biomarkers combined with traditional biomarkers or miRNA signatures generated from microchips may serve as a great predictive tool for PE occurrence and prognosis. Further, therapies targeting miRNAs or their upstream/downstream molecules need to be developed more quickly to keep up with the progress of routine treatments, such as anticoagulation, thrombolysis, or surgery.
first_indexed 2024-04-11T15:10:42Z
format Article
id doaj.art-95dd1af2a01f4a578d18c45268e227e5
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-11T15:10:42Z
publishDate 2021-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-95dd1af2a01f4a578d18c45268e227e52022-12-22T04:16:39ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-10-011210.3389/fphar.2021.743945743945The Function of microRNAs in Pulmonary Embolism: Review and Research OutlookMingyao Luo0Mingyuan Du1Mingyuan Du2Chang Shu3Chang Shu4Chang Shu5Sheng Liu6Jiehua Li7Jiehua Li8Lei Zhang9Lei Zhang10Xin Li11Xin Li12State Key Laboratory of Cardiovascular Diseases, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, ChinaThe Institute of Vascular Diseases, Central South University, Changsha, ChinaState Key Laboratory of Cardiovascular Diseases, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, ChinaThe Institute of Vascular Diseases, Central South University, Changsha, ChinaState Key Laboratory of Cardiovascular Diseases, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, ChinaThe Institute of Vascular Diseases, Central South University, Changsha, ChinaDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, ChinaThe Institute of Vascular Diseases, Central South University, Changsha, ChinaDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, ChinaThe Institute of Vascular Diseases, Central South University, Changsha, ChinaPulmonary embolism (PE) is a common pathologic condition that frequently occurs in patients with deep venous thrombosis. Severe PE may critically suppress cardiopulmonary function, thereby threatening the life of patients. Chronic pulmonary hypertension caused by PE may lead to deterioration of respiratory dysfunction, resulting in complete disability. MicroRNAs (miRNAs) are a group of abundantly expressed non-coding RNAs that exert multiple functions in regulating the transcriptome via post-transcriptional targeting of mRNAs. Specifically, miRNAs bind to target mRNAs in a matching mechanism between the miRNA seed sequence and mRNA 3ʹ UTR, thus modulating the transcript stability or subsequent translation activity by RNA-induced silencing complex. Current studies have reported the function of miRNAs as biomarkers of PE, revealing their mechanism, function, and targetome in venous thrombophilia. This review summarizes the literature on miRNA functions and downstream mechanisms in PE. We conclude that various related miRNAs play important roles in PE and have great potential as treatment targets. For clinical application, we propose that miRNA biomarkers combined with traditional biomarkers or miRNA signatures generated from microchips may serve as a great predictive tool for PE occurrence and prognosis. Further, therapies targeting miRNAs or their upstream/downstream molecules need to be developed more quickly to keep up with the progress of routine treatments, such as anticoagulation, thrombolysis, or surgery.https://www.frontiersin.org/articles/10.3389/fphar.2021.743945/fullmiRNAbiomarkertreatment targetpulmonary embolismdeep venous thrombosismolecular regulation
spellingShingle Mingyao Luo
Mingyuan Du
Mingyuan Du
Chang Shu
Chang Shu
Chang Shu
Sheng Liu
Jiehua Li
Jiehua Li
Lei Zhang
Lei Zhang
Xin Li
Xin Li
The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook
Frontiers in Pharmacology
miRNA
biomarker
treatment target
pulmonary embolism
deep venous thrombosis
molecular regulation
title The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook
title_full The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook
title_fullStr The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook
title_full_unstemmed The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook
title_short The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook
title_sort function of micrornas in pulmonary embolism review and research outlook
topic miRNA
biomarker
treatment target
pulmonary embolism
deep venous thrombosis
molecular regulation
url https://www.frontiersin.org/articles/10.3389/fphar.2021.743945/full
work_keys_str_mv AT mingyaoluo thefunctionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT mingyuandu thefunctionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT mingyuandu thefunctionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT changshu thefunctionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT changshu thefunctionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT changshu thefunctionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT shengliu thefunctionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT jiehuali thefunctionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT jiehuali thefunctionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT leizhang thefunctionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT leizhang thefunctionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT xinli thefunctionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT xinli thefunctionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT mingyaoluo functionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT mingyuandu functionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT mingyuandu functionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT changshu functionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT changshu functionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT changshu functionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT shengliu functionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT jiehuali functionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT jiehuali functionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT leizhang functionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT leizhang functionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT xinli functionofmicrornasinpulmonaryembolismreviewandresearchoutlook
AT xinli functionofmicrornasinpulmonaryembolismreviewandresearchoutlook